- ISHITA DRUGS INDUSTRIES LTD
ISHITA DRUGS INDUSTRIES LTD
BSE: 524400
₹76.99
+₹1.08 (1.42%) TodayLast updated on 05 May, 2025 | 15:05 ISTMarket cap  ₹23 Crs | Open ₹78.95 | Prev. Close ₹75.91 |
Circuit range ₹91.09 - ₹60.73 | Day range ₹71.10 - ₹78.95 | Year range ₹56.00 - ₹104.75 |
Volume 1,586 | Avg. traded ₹74.25 | Revenue (12m) ₹15 Crs |
About ISHITA DRUGS INDUSTRIES LTD
Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.
ISHITA DRUGS INDUSTRIES LTD Share Price Chart
Please wait...
ISHITA DRUGS INDUSTRIES LTD Fundamentals
ISHITA DRUGS INDUSTRIES LTD Key indicators
52 week high ₹104.75 | 52 week low ₹56.00 | P/E ratio 26.33 |
P/B ratio 2.38 | ROE 7.84% | ROCE 10.74% |
Dividend yield -- | Debt/Equity ratio | EPS 2.5 |
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
ISHITA DRUGS INDUSTRIES LTD Financial Ratios
Operating profit margin7.83% | Net profit margin4.93% |
ROE7.84% | ROA6.74% |
ROCE10.74% |
Quick ratio9.91 | Current ratio11.14 |
Interest coverage12 | Asset turnover1.37 |
Debt to Equity0 |
P/E ratio26.33 | P/B ratio2.38 |
EV / EBITDA12.45 | |
Dividend yield0% |
Revenue statement
All values are in ₹ Crores (Cr)
Loading chart data
Cash flow
All values are in ₹ Crores (Cr)
Loading chart data
Balance sheet
All values are in ₹ Crores (Cr)
No data available at the moment
Total assets
Total liabilities
ISHITA DRUGS INDUSTRIES LTD Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Mon, May 5 2025 | ₹78.95 | ₹76.99 | |
Fri, May 2 2025 | ₹70.90 | ₹75.91 | -6.86% |
Wed, Apr 30 2025 | ₹81.86 | ₹81.50 | -0.94% |
Tue, Apr 29 2025 | ₹82.00 | ₹82.27 | -1.44% |
Mon, Apr 28 2025 | ₹79.50 | ₹83.47 | |
Fri, Apr 25 2025 | ₹77.00 | ₹78.50 | |
Thu, Apr 24 2025 | ₹79.00 | ₹77.83 | -1.52% |
Wed, Apr 23 2025 | ₹79.90 | ₹79.03 | -1.09% |
More
Stocks Similar to ISHITA DRUGS INDUSTRIES LTD
Popular Stocks
ISHITA DRUGS INDUSTRIES LTD News
FAQs on ISHITA DRUGS INDUSTRIES LTD
What is the ISHITA DRUGS INDUSTRIES LTD share price today?
ISHITA DRUGS INDUSTRIES LTD share price is ₹ 76.99 as on 06 May, 2025 | 00:18 IST
What is today’s high & low share price of ISHITA DRUGS INDUSTRIES LTD?
ISHITA DRUGS INDUSTRIES LTD share price high: ₹ 78.95 and low: ₹ 71.10 as on 06 May, 2025 | 00:18 IST
What is the ISHITA DRUGS INDUSTRIES LTD share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 104.75 and Low Price is ₹ 56.00 as on 06 May, 2025 | 00:18 IST
What is the ISHITA DRUGS INDUSTRIES LTD Stock Symbol?
The ISHITA DRUGS INDUSTRIES LTD Stock symbol is ISHITADR.
Can I buy ISHITA DRUGS INDUSTRIES LTD shares on Holidays?
No, shares of ISHITA DRUGS INDUSTRIES LTD or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ISHITA DRUGS INDUSTRIES LTD shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.